The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization
- 1 January 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 32 (2) , 214-237
Abstract
Epidemiological trends in cancer research show that lung cancer can affect up to 1 in 15 men and 1 in 17 women. With incidence rates as high as these and significant associated mortality and morbidity, it is no wonder that lung cancer is one of the main areas of research focused on cancer. Advances in targeted treatments and specialized irradiation protocols have allowed the treatment of more advanced cases. However, as the patient numbers grow, so does the need for cancer-preventive strategies. The present narrative review focuses on soy isoflavones' role in the chemoprevention of lung cancer and their possible role in therapeutic adjuncts. Laboratory studies on lung cancer cell lines have shown that isoflavones can induce apoptosis, tamper with the expression of proliferative molecular pathways, and even reduce tumor angiogenesis. Additionally, population-level studies have emerged that correlate the consumption of isoflavonoids with reduced risk for the development of lung cancer. Interestingly enough, the literature also contains small-scale studies with evidence of isoflavones being effective chemotherapeutic adjuncts that are currently understudied. Our literature review underlines such findings and provides a call for the enhancement of research regarding naturally occurring dietary products with possible anticarcinogenic effects.Keywords
This publication has 167 references indexed in Scilit:
- Soy isoflavone genistein inhibits hsa_circ_0031250/miR‐873‐5p/FOXM1 axis to suppress non‐small‐cell lung cancer progressionIUBMB Life, 2020
- Natural products and their derivatives: Promising modulators of tumor immunotherapyJournal of Leukocyte Biology, 2020
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung CancerJAMA, 2019
- Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trialInternational Journal of Cancer, 2019
- PD‐1/PD‐L1 pathway: Basic biology and role in cancer immunotherapyJournal of Cellular Physiology, 2019
- Surgery for limited-stage small-cell lung cancerCochrane Database of Systematic Reviews, 2017
- Soy, isoflavones, and prostate cancerMolecular Nutrition & Food Research, 2009
- Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia‐inducible factor‐1 alphaInternational Journal of Cancer, 2007
- Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasmaCancer, 2007
- The methylation status and protein expression of CDH1, p16INK4A, and fragile histidine triad in nonsmall cell lung carcinomaCancer, 2006